EQS-Adhoc: Alzchem Group AG raises EBITDA forecast into the range of EUR 80 million for fiscal year 2023 despite slightly lower sales expectation
|
EQS-Ad-hoc: Alzchem Group AG / Key word(s): Change in Forecast
Alzchem Group AG raises EBITDA forecast into the range of EUR 80 million for fiscal year 2023 despite slightly lower sales expectation
18-Oct-2023 / 16:23 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Alzchem Group AG is significantly raising its earnings forecast for the fiscal year 2023 despite a slightly lower sales expectation. Group EBITDA is expected to grow to approximately EUR 80 million (original forecast: up to EUR 70 million). Group sales are expected to be at or slightly below the previous year’s level of EUR 542.2 million; this is slightly below the most recent forecast.
The higher earnings forecast is based primarily on the very positive development of the high-margin specialty chemicals business. Particularly noteworthy in this respect are the products from the Human Nutrition (Creapure®) and Animal Nutrition (Creamino®) businesses, as well as the guanidine salts (nitroguanidine).
The forecasts for fiscal year 2023 made in the consolidated financial statements as of 31 December 2022 and last specified in July 2023 are therefore adjusted overall as follows:
| |
2022 |
Original forecast 2023 (according to last specification) |
Adjusted forecast 2023 |
| Group sales |
EUR 542.2 million |
Slightly growing |
At previous year’s level or slightly below |
| Adjusted EBITDA* |
EUR 61.4 million |
Up to EUR 70 million |
Strongly growing to approx. EUR 80 million |
Adjusted
EBITDA margin* |
11.3% |
Up to 12% |
Noticeably growing |
| Inventories |
EUR 122.4 million |
Stable |
Slightly to significantly decreasing |
Inventory intensity
(previously inventory ratio) |
22.6% |
Stable |
Slightly to significantly decreasing |
| Equity ratio |
34.5% |
Noticeably growing |
Significantly growing |
| * No adjustments were made. |
End of Inside Information
18-Oct-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
|
| Language: |
English |
| Company: |
Alzchem Group AG |
|
Dr.-Albert-Frank-Str. 32 |
|
83308 Trostberg |
|
Germany |
| Phone: |
+498621862888 |
| Fax: |
+49862186502888 |
| E-mail: |
[email protected] |
| Internet: |
www.alzchem.com |
| ISIN: |
DE000A2YNT30 |
| WKN: |
A2YNT3 |
| Listed: |
Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart |
| EQS News ID: |
1752073 |
| |
| End of Announcement |
EQS News Service |
1752073 18-Oct-2023 CET/CEST
|
Die wichtigsten Finanzdaten auf einen Blick
|
| |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023e |
| Umsatzerlöse1 |
344,00 |
375,22 |
376,07 |
379,26 |
422,29 |
542,22 |
540,65 |
| EBITDA1,2 |
43,30 |
49,38 |
50,08 |
53,81 |
62,05 |
61,44 |
81,37 |
| EBITDA-Marge3 |
12,59 |
13,16 |
13,32 |
14,19 |
14,69 |
11,33 |
|
| EBIT1,4 |
27,20 |
34,19 |
30,59 |
30,71 |
37,57 |
35,90 |
55,47 |
| EBIT-Marge5 |
7,91 |
9,11 |
8,13 |
8,10 |
8,90 |
6,62 |
10,26 |
| Jahresüberschuss1 |
16,50 |
22,78 |
18,15 |
19,87 |
27,76 |
30,22 |
34,79 |
| Netto-Marge6 |
4,80 |
6,07 |
4,83 |
5,24 |
6,57 |
5,57 |
6,44 |
| Cashflow1,7 |
33,00 |
34,66 |
43,63 |
48,71 |
43,02 |
-4,24 |
72,67 |
| Ergebnis je Aktie8 |
1,90 |
2,30 |
1,77 |
1,94 |
2,72 |
2,96 |
3,40 |
| Dividende8 |
1,10 |
0,90 |
0,75 |
0,77 |
1,00 |
1,05 |
0,00 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2023 - Kostenfrei herunterladen. 
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: RSM Ebner Stolz
|
| INVESTOR-INFORMATIONEN |
| ©boersengefluester.de |
| AlzChem Group |
| WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
| A2YNT3 |
45,600 |
Kaufen |
464,04 |
| KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
| 13,82 |
13,77 |
1,00 |
19,17 |
| KBV |
KCV |
KUV |
EV/EBITDA |
| 3,11 |
6,39 |
0,86 |
7,50 |
| Dividende '22 in € |
Dividende '23e in € |
Div.-Rendite '23e
in % |
Hauptversammlung |
| 1,05 |
1,20 |
2,63 |
07.05.2024 |
| Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
| 30.04.2024 |
01.08.2024 |
07.11.2024 |
01.03.2024 |
| Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
| 36,70% |
78,66% |
75,38% |
140,00% |
|
|
Alzchem Group AG DE000A2YNT30